Treatment by miglustat of a young adult presenting type 1 Gaucher's disease

被引：0
|
作者：
Djerad, Hama [1 ]
机构：
[1] Ctr Hosp Nevers, Serv Med Interne, F-58000 Nevers, France
来源：
PRESSE MEDICALE | 2006年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S33 / S34
页数：2
相关论文
共 50 条
  • [1] Treatment by miglustat of an elderly patient with Gaucher's disease type 1
    de Roux-Serratrice, Christine
    Serratrice, Jacques
    Disdier, Patrick
    Weiller, Pierre-Jean
    PRESSE MEDICALE, 2006, 35 : S30 - S32
  • [2] ADULT PATIENTS WITH TYPE I GAUCHER DISEASE (GD 1) ON LONG-TERM MIGLUSTAT TREATMENT
    Hollak, C.
    Heitner, R.
    Hrebicek, M.
    Elstein, D.
    Zimran, A.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2005, 28 : 171 - 171
  • [3] Short-term effect of oral treatment with miglustat in type 1 Gaucher disease.
    Giraldo, P
    Alonso, D
    Acedo, M
    Franco, R
    Barez, A
    Corrales, A
    Serrano, D
    Roldan, V
    Latre, P
    Alfonso, P
    Pocovi, M
    BLOOD, 2005, 106 (11) : 629A - 630A
  • [4] Twelve years of experience with miglustat in the treatment of type 1 Gaucher disease: The Spanish ZAGAL project
    Giraldo, Pilar
    Andrade-Campos, Marcio
    Alfonso, Pilar
    Irun, Pilar
    Atutxa, Koldo
    Acedo, Antonio
    Barez, Abelardo
    Blanes, Margarita
    Diaz-Morant, Vicente
    Angeles Fernandez-Galan, Ma
    Franco, Rafael
    Gil-Cortes, Cristina
    Giner, Vicente
    Ibanez, Angela
    Latre, Paz
    Loyola, Ines
    Luno, Elisa
    Hernandez-Martin, Roberto
    Medrano-Engay, Blanca
    Puerta, Jose
    Roig, Inmaculada
    de la Serna, Javier
    Salamero, Olga
    Villalon, Lucia
    Pocovi, Miguel
    BLOOD CELLS MOLECULES AND DISEASES, 2018, 68 : 173 - 179
  • [5] Randomized, Controlled Trial of Miglustat in Gaucher's Disease Type 3
    Schiffmann, Raphael
    Fitzgibbon, Edmond J.
    Harris, Chris
    DeVile, Catherine
    Davies, Elin H.
    Abel, Larry
    van Schaik, Ivo N.
    Benko, William
    Timmons, Margaret
    Ries, Markus
    Vellodi, Ashok
    ANNALS OF NEUROLOGY, 2008, 64 (05) : 514 - 522
  • [6] TEN YEARS OF EXPERIENCE WITH MIGLUSTAT IN TREATMENT OF TYPE 1 GAUCHER DISEASE: THE SPANISH ZAGAL PROJECT
    Giraldo, P.
    Andrade, M.
    Alfonso, P.
    Irun, P.
    Atucha, L.
    Acedo, A.
    Diaz-Morant, V.
    Barez, A.
    Fernandez-Galan, M.
    Franco, R.
    Giner, V.
    Loyola, I.
    Luno, E.
    de la Serna, J.
    Villalon, L.
    Salamero, O.
    Pocovi, M.
    HAEMATOLOGICA, 2014, 99 : 764 - 764
  • [7] Guidance on the use of miglustat for treating patients with type 1 Gaucher disease
    Weinreb, NJ
    Barranger, JA
    Charrow, J
    Grabowski, GA
    Mankin, HJ
    Mistry, P
    AMERICAN JOURNAL OF HEMATOLOGY, 2005, 80 (03) : 223 - 229
  • [8] Multimorbidity in type 1 Gaucher disease patients under miglustat therapy
    Engay, Blanca Medrano
    Roy, Ana
    Atutxa, Koldo
    Diaz-Morant, Vicente
    Garcia-Frade, Javier
    Hernandez-Martin, Roberto
    Luno, Elisa
    Noya, Soledad
    de la Serna, Javier
    Villalon, Lucia
    Giraldo, Pilar
    MOLECULAR GENETICS AND METABOLISM, 2018, 123 (02) : S93 - S94
  • [9] Clinical benefits of miglustat on bone disease in adult type 1 Gaucher disease (GD1): A meta-analysis
    Pastores, G. M.
    Elstein, D.
    Hrebicek, M.
    Zimran, A.
    CALCIFIED TISSUE INTERNATIONAL, 2007, 80 : S68 - S68
  • [10] Oral maintenance with miglustat in adult patients with type 1 Gaucher disease: The patients quality-of-life perspective
    Elstein, D.
    Dweck, A.
    Attias, D.
    Hadas-Halpern, I
    Zevin, S.
    Altarescu, G.
    Zimran, A.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2007, 30 : 120 - 120
12345